---
title: Axplora vs HAS Healthcare Advanced Synthesis SA
slug_a: axplora
slug_b: hashealthcare
site: cdmo
review_signal_gate: closed
canonical_path: /compare/axplora/hashealthcare
generated_by: BioBM Editorial AI
---

# Axplora vs HAS Healthcare Advanced Synthesis SA

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Axplora (axplora) is listed for cdmo. Global CDMO and API manufacturer specializing in complex small molecule development, ADC manufacturing, HPAPIs, and hazardous chemistry across ten production sites in Europe, India, and the US.

Services: 13. Modalities: 2. Indications: 6. Locations: 10. Certifications: 7. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (13).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

HAS Healthcare Advanced Synthesis SA (hashealthcare) is listed for cdmo. HAS Healthcare Advanced Synthesis is a Swiss CDMO producing cGMP APIs, HPAPIs and anticancer compounds from clinical to commercial use. Recent Swissmedic milestones include approval of its expanded Reduced Folates unit and inspection of its new ADC suite.

Services: 5. Modalities: 2. Indications: 1. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.